Mobile

An international study to assess the safety and efficacy of a combination of an approved drug combination in different type of patient, namely patients acutely infected with Hepatitis C virus who are ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-004812-12

An international study to assess the safety and efficacy of a combination of an approved drug combination in different type of patient, namely patients acutely infected with Hepatitis C virus who are also chronically infected with Human Immunodeficiency Virus (HIV)-1

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is as follows: • To determine the antiviral efficacy of LDV/SOF FDC Tablet as measured by the proportion of subjects who attain SVR at 12 weeks after discontinuation of therapy (SVR12) • To evaluate the safety and tolerability of LDV/SOF FDC as assessed by review of the accumulated safety data

Critère d'inclusion

  • Acute Genotype 1 or Genotype 4 Hepatitis C Virus Infection

Liens